Results 21 to 30 of about 25,910 (264)

Multiomics prediction and immunogenic validation of personalized neoantigens in cholangiocarcinoma patients [PDF]

open access: yesJournal of Translational Medicine
Background Cholangiocarcinoma (CCA) is an aggressive biliary tract cancer with limited treatment options, underscoring the need for breakthrough precision therapies. Neoantigen-based therapy is a promising novel strategy for cancer treatment.
Baoluhe Zhang   +14 more
doaj   +2 more sources

DNA-PK inhibition enhances neoantigen diversity and increases T cell responses to immunoresistant tumors

open access: yesThe Journal of Clinical Investigation
Effective antitumor T cell activity relies on the expression and MHC presentation of tumor neoantigens. Tumor cells can evade T cell detection by silencing the transcription of antigens or by altering MHC machinery, resulting in inadequate neoantigen ...
Allison J. Nielsen   +15 more
doaj   +2 more sources

Profiling immunogenic neoantigen peptides elicited by personalized neoantigen vaccine in cancer patients [PDF]

open access: yesFrontiers in Immunology
IntroductionPersonalized neoantigen vaccines can induce antitumor T cell responses, but only 10-20% of selected peptides have induced immune responses in patients, underscoring the limitations of current prediction strategies.MethodsWe analyzed a ...
Peng Zhao   +14 more
doaj   +2 more sources

NeoFox: annotating neoantigen candidates with neoantigen features

open access: yesBioinformatics, 2021
Abstract Summary The detection and prediction of true neoantigens is of great importance for the field of cancer immunotherapy. Wesearched the literature for proposed neoantigen features and integrated them into a toolbox called NEOantigen Feature toolbOX (NeoFox).
Franziska Lang   +4 more
openaire   +3 more sources

Identification of neoantigens in esophageal adenocarcinoma [PDF]

open access: yesImmunology, 2022
Abstract Esophageal adenocarcinoma (EAC) has a relatively poor long-term survival and limited treatment options. Promising targets for immunotherapy are short peptide neoantigens containing tumor mutations, presented to cytotoxic T-cells by human leukocyte antigen molecules (HLA).
Ben Nicholas   +10 more
openaire   +3 more sources

tianshilu/QBRC-Neoantigen-Pipeline: First release

open access: yes, 2021
QBRC Neoantigen calling pipeline with CSiN calculation ...
Neoantigen-pipeline, tianshilu
core   +1 more source

Targeting tumor heterogeneity with neoantigen-based cancer vaccines

open access: yes, 2023
Neoantigen-based cancer vaccines have emerged as a promising immunotherapeutic approach to treat cancer. Nevertheless, the high degree of heterogeneity in tumors poses a significant hurdle for developing a vaccine that targets the therapeutically ...
Chen, Shuxiong   +5 more
core   +1 more source

neoantigen pipeline

open access: yes, 2023
<p>Neoantigen Prediction Pipeline</p> <p>Human Antigen Presentation Score</p ...
Zhu Xiuli
core   +1 more source

neoDL: a novel neoantigen intrinsic feature-based deep learning model identifies IDH wild-type glioblastomas with the longest survival

open access: yesBMC Bioinformatics, 2021
Background Neoantigen based personalized immune therapies achieve promising results in melanoma and lung cancer, but few neoantigen based models perform well in IDH wild-type GBM, and the association between neoantigen intrinsic features and prognosis ...
Ting Sun   +15 more
doaj   +1 more source

Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion

open access: yesMolecular Cancer, 2021
Background Clinically, prophylactic anti-recurrence treatments for hepatocellular carcinoma (HCC) patients after radical surgery are extremely limited.
Zhixiong Cai   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy